1. Home
  2. ESEA vs EOLS Comparison

ESEA vs EOLS Comparison

Compare ESEA & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Euroseas Ltd. (Marshall Islands)

ESEA

Euroseas Ltd. (Marshall Islands)

SELL

Current Price

$65.17

Market Cap

557.0M

ML Signal

SELL

Logo Evolus Inc.

EOLS

Evolus Inc.

SELL

Current Price

$6.63

Market Cap

500.0M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
ESEA
EOLS
Founded
2005
2012
Country
Greece
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
557.0M
500.0M
IPO Year
2005
2018

Fundamental Metrics

Financial Performance
Metric
ESEA
EOLS
Price
$65.17
$6.63
Analyst Decision
Strong Buy
Buy
Analyst Count
4
6
Target Price
★ $91.75
$15.40
AVG Volume (30 Days)
20.2K
★ 736.8K
Earning Date
11-17-2026
11-04-2026
Dividend Yield
★ 4.90%
N/A
EPS Growth
N/A
★ 1.23
EPS
★ N/A
N/A
Revenue
N/A
★ $297,176,000.00
Revenue This Year
N/A
$12.48
Revenue Next Year
$3.94
$16.86
P/E Ratio
$3.39
★ N/A
Revenue Growth
N/A
★ 11.61
52 Week Low
$51.00
$3.86
52 Week High
$79.67
$9.31

Technical Indicators

Market Signals
Indicator
ESEA
EOLS
Relative Strength Index (RSI) 41.04 39.77
Support Level $63.29 $6.42
Resistance Level $72.56 $7.17
Average True Range (ATR) 2.13 0.41
MACD 0.30 -0.02
Stochastic Oscillator 27.21 15.73

Price Performance

Historical Comparison
ESEA
EOLS

About ESEA Euroseas Ltd. (Marshall Islands)

Euroseas Ltd is a shipping company. Its fleet consists of containerships that transport container boxes, providing scheduled service between ports. Its operations are managed by an affiliated ship management company, which is responsible for the day-to-day commercial and technical management and operations of the vessels. The company employs its vessels on spot and period charters and through pool arrangements.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The line includes several products, including mid face, nasolabial folds, lips, and eyes. Geographically, the company currently has operations in the United States, Canada, Europe, and Australia.

Share on Social Networks: